- Open Access
The establishment of a duplex real-time PCR assay for rapid and simultaneous detection of blaNDM and blaKPC genes in bacteria
Annals of Clinical Microbiology and Antimicrobials volume 12, Article number: 30 (2013)
The latest threat of multidrug-resistant Gram-negative bacteria corresponds to the emergence of carbapenemase New Delhi metallo-β-lactamase (NDM) and Klebsiella pneumoniae carbapenemase (KPC) producers. Rapid molecular detection is essential to limit their spread. In this study, a duplex real-time polymerase chain reaction (PCR) that was specific for the detection of blaNDM and bl aKPC with the same limit of detection of ten plasmid copies was developed. The assay was linear over eight log dilutions for blaNDM (R2 = 0.971; slope, -3.273) and blaKPC (R2 = 0.992; slope, -2.997) with efficiencies of 102% and 115%, respectively. The assay was validated with 157 clinical isolates and showed 100% concordance with conventional PCR. The excellent performance of the duplex PCR assay makes it a powerful tool for surveillance of the carbapenemases NDM and KPC.
Carbapenems such as imipenem and meropenem are considered the drugs of choice for treating severe infections caused by Enterobacteriaceae-producing extended-spectrumβ-lactamases (ESBLs). Increasing resistance to carbapenems is now frequently observed in many hospital-acquired and community-acquired Enterobacteriaceae rods [1, 2]. The association of carbapenem-resistant Enterobacteriaceae (CRE) with therapeutic failure and the resulting high mortality rates is of serious concern. Although several mechanisms of carbapenem resistance have been reported, the production of carbapenemases is the most common mechanism . A large variety of clinically relevant carbapenemases, including Guiana extended-spectrum β-lactamases (GES), Klebsiella pneumoniae carbapenemase (KPC), Verona integron-encoded metallo-β-lactamase (VIM), imipenem-hydrolyzing β-lactamases (IMP), Sao Paulo metallo-β-lactamase (SPM), German imipenemase (GIM), Seoul imipenemase (SIM), and oxacillinase-48 (OXA-48) type, and rapidly emerging New Delhi metallo-β-lactamaseo-1 (NDM-1) have been reported [1, 3]. In particular, since KPC producers were first reported in the United States in 1996 and NDM producers were first reported in India in 2008, both have rapidly emerged worldwide as important causes of extreme drug resistance [3–5].
The increasingly common class A enzyme KPCs and the latest metallo-β-lactamase NDMs are able to hydrolyze nearly all β-lactams; moreover, almost all of their producers are broadly resistant to other drug classes in addition to β-lactams due to a diversity of other resistance mechanisms (e.g. to aminoglycosides and fluoroquinolones), leaving physicians with limited antibiotic choices for treating infected patients [1, 6, 7]. KPC enzymes have been reported in numerous Enterobacteriaceae genera and even in non-fermenting bacteria, although KPCs are mostly identified from K. pneumoniae. In addition, KPC-producing isolates have disseminated worldwide, including several countries across Asia, America and Europe. The blaKPC genes are almost present on transferable plasmids and are flanked by transposable elements [8–10], which allows for potential dissemination among different species. Similarly, the blaNDM genes are primarily located on plasmids belonging to several incompatibility groups, and the diversity of genetic features associated with the blaNDM genes may explain its current high worldwide spread rate [11, 12]. NDM enzymes have been recognized among different Enterobacteriaceae species as well as in non-fermenters and Vibrionaceae and have been reported worldwide in Asia, Europe, North America, Australia and the Middle East since 2008. To date, thirteen blaKPC gene variants (classified in sequential numeric order from blaKPC-1/2 to blaKPC-15) have been described and six minor NDM variants (blaNDM-2 to blaNDM-8) have been identified (http://www.lahey.org/studies/).
The carbapenemases KPC and NDM have already become a worldwide public health issue due to their widespread distribution, broad range of activity against β-lactams and aggressive hazards to human beings. As a result, the sensitive and rapid detection of the blaNDM and blaKPC genes is essential for implementation of the infection control procedures that are required to limit their spread and to help clinicians guide individual patient management. In this study, we developed a duplex TaqMan probe-based real-time polymerase chain reaction (PCR) assay for the prompt and simultaneous detection of the blaNDM and blaKPC genes in bacteria in a single tube.
Materials and methods
Primer and probe design
The details of the reference genes used in this assay are provided at http://www.lahey.org/studies/. The reference gene sequences for the NDM and KPC enzyme families were assembled from GenBank (http://www.ncbi.nlm.nih.gov/GenBank) as NDM accession numbers FN396876, JF703135, JQ734687, JQ348841, JN104597, JN967644, JX262694 and AB744718 representing alleles 1–8 and as KPC accession numbers AY034847, AF395881, AY700571, EU400222, EU555534, EU729727, FJ234412, FJ624872, GQ140348, HM066995, HQ641421, HQ342890, JX524191 and KC433553 representing alleles 2–15. Based on the comprehensive analyses and alignments of both gene families, primers and probes for the duplex real-time PCR assay were specifically designed to amplify all alleles of each gene family described above using Beacon Designer software (Premier Biosoft, Palo Alto, CA, USA) (Table 1). All of the primers and probes were synthesized by TaKaRa Bio, Inc. (Dalian, China).
Recombinant plasmids pNDM-1 and pKPC-2
The recombinant plasmids pNDM-1 and pKPC-2, composed of a pMD18-T backbone carrying a 4-kb insert expressing NDM-1 and KPC-2 carbapenemase, respectively, were used to optimize the quantitative PCR (qPCR).
Bacterial strains and antibiotic susceptibility testing
A total of 157 Enterobacteriaceae isolates were collected at Nanfang Hospital from June 2010 to September 2012, including 17 resistant to imipenem or meropenem isolates and 140 randomly collected isolates with susceptible to imipenem and meropenem. All the isolates had previously been tested for blaKPC, blaIMP, blaVIM, blaNDM and blaOXA-48 using conventional PCR and sequencing [13–15]. Of them, 17 carbapenem–resistant isolates harbored the carbapenemase genes blaKPC, blaIMP or blaNDM, including nine blaKPC-2-positive K. pneumoniae, one K. pneumoniae carrying blaKPC-2 and blaIMP-4, three blaNDM-1-positive K. pneumoniae, one Klebsiella oxytoca and one each blaNDM-1-positive Enterobacter hormaechei, Enterobacter cloacae and Enterobacter aerogenes. The other 140 Enterobacteriaceae isolates were negative for the five tested carbapenemase genes. In addition, ten NDM/KPC non-producers, including Escherichia coli ATCC 25922, K. pneumoniae ATCC 700603, Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa ATCC 27853 and six known clinical strains without any carbapenemase gene(two Enterococcus spp., two Streptococcus spp. and two Staphylococcus spp.), were used to evaluate the specificity of the duplex qPCR assay.
All bacterial identification and susceptibility testing was performed using a BD Phoenix 100 Automated Microbiology System (Benton, Dickinson and Co., Franklin Lakes, NJ, USA). The results were interpreted according to the Clinical and Laboratory Standards Institute guidelines. The isolates were stored at -80°C in nutrient broth containing 30% (v/v) glycerol.
Fresh, well-isolated colonies were used for total bacterial DNA extraction using a TaKaRa MiniBEST DNA Fragment Purification Kit Ver.3.0 (TaKaRa Bio, Inc.) according to the manufacturer’s protocol. Extracted DNA was eluted from the columns in 100 μL of elution buffer and stored at -20°C.
Duplex real-time PCR reaction
The TaqMan probe-based real-time PCR assay was performed on an ABI Prism 7500 Fast apparatus (Applied Biosystems, Foster City, CA, USA) using the Premix Ex Taq™ (Probe qPCR) kit (TaKaRa Bio, Inc.) as recommended by the manufacturer. The 20-μL qPCR mixture contained 2 μL of DNA extract solution, 10 μL of Premix Ex Taq Probe qPCR (2×), 0.4 μL of ROX Reference Dye II (50×), 0.2 μM of each primer and 0.1 μM of each TaqMan probe, and sterile water to a final volume of 20 μL. The optimal cycling conditions were 20 s at 95°C and 40 cycles each of 3 s at 95°C and 30 s at 60°C. Each run contained a positive control (mixture of recombinant plasmids pNDM-1 and pKPC-2) for blaNDM and blaKPC amplification and at least one water blank as a negative control.
Standard curve and sensitivity test on recombinant plasmids
To determine the efficiency of the duplex real-time PCR assay, Ct values obtained from a series of template DNA dilutions were graphed on the y axis versus the log of the dilution on the x axis. The slope of this line was used to determine efficiency (E) according to this equation: E = 10(-1/slope). Assay sensitivity and reproducibility were estimated by serial ten-fold dilution experiments using the mixture of recombinant plasmids pNDM-1 and pKPC-2.
The assay was initially validated using the recombinant plasmids pNDM-1 and pKPC-2 carrying the blaNDM-1 and blaKPC-2 genes. Clearly defined amplification curves were observed for the two positive recombinant plasmids in their predicted fluorescence channels.
Primer and probe specificities were evaluated at the National Center for Biotechnology Information database (http://www.ncbi.nlm.nih.gov). No matches to the primer or probe sequences of blaNDM and blaKPC were found other than those for corresponding blaNDM and blaKPC genes. The analytical specificity was also applied on clinically representative bacteria with no known antibiotic resistance gene, including E. coli ATCC 25922, K. pneumoniae ATCC 700603, S. aureus ATCC 25923, P. aeruginosa ATCC 27853, Enterococcus spp. (two isolates), Staphylococcus spp. (two isolates) and Streptococcus spp. (two isolates). The recombinant plasmids pNDM-1 and pKPC-2 were used as positive controls. No amplification of blaNDM or blaKPC was observed with DNA extracted from any of the ten organisms on our specificity test panel. Thus, the specificity of our duplex PCR is considered satisfactory.
Assay linearity and limit of detection were determined by performing serial ten-fold dilutions of a mixture of the recombinant plasmids pNDM-1 and pKPC-2 from 10 to 108 copies/μL (Figure 1). The assay correlated well with blaNDM (R2 = 0.971) and blaKPC (R2 = 0.992) over the entire copy range with an efficiency of 102% and 115%, respectively. The limit of detection for both targets was 10 copies per 20-μL reaction volume.
We have also shown that the assay was highly stable and precise as evidenced by the performance of the recombinant plasmid pNDM-1 (105 copies of blaNDM-1-carrying plasmid) and pKPC-2 (105 copies of blaKPC-2-carrying plasmid), which were stable over five consecutive runs for both blaNDM (mean Ct, 22.8; standard deviation, 0.4; coefficient of variation, 1.8%) and blaKPC (mean Ct, 19.3; standard deviation, 0.1; coefficient of variation, 0.5%).
Finally, when tested against the 157 previously characterized carbapenem-resistant Enterobacteriaceae isolates, including seven with NDM-1 metallo-carbapenemases, ten with KPC-2 serine carbapenemases and 140 strains without blaNDM and blaKPC carbapenemases, the duplex PCR assay showed 100% concordance with conventional PCR previously identified. In our opinion, the 100% sensitivity and specificity of the duplex PCR validated against clinical isolates of carbapenem-resistant Gram-negative bacilli with well-defined carbapenemase genes make it a useful tool for the screening and surveillance of isolates carrying the carbapenemase genes blaNDM and blaKPC.
The co-occurrence of blaNDM-1 and blaKPC-2 in a clinical isolate of K. pneumoniae from India was recently reported , suggesting that the growing emergence of these powerful resistance mechanisms should be given great attention. Considering the difficulty in preventing their emergence due to the potential for rapid horizontal and vertical transmission determined by genetics and treating patients infected with blaNDM and blaKPC harboring bacterial pathogens, active surveillance and early detection are mandatory for preventing their further spread.
Molecular assays have been reported to identify carbapenemase genes in Gram-negative bacteria. Several real-time PCR assays targeting NDM-1 or KPC have been described [16–20], but each targets only one kind of carbapenemase gene. Assays that target more than one class of carbapenemase (A, B, D) have been developed [15, 21], but each of those uses conventional PCR requiring post-amplification analysis. Real-time PCR requiring less time and labor for the simultaneous detection of multiple carbapenemase genes including NDM and KPC is rare. Monteiro et al. described a multiplex real-time PCR for the rapid detection of KPC, GES, NDM, IMP, VIM and OXA-48 carbapenemase genes using melt curve analysis , however, no details of the assay design for the detection of all blaNDM types other than blaNDM-1 were provided. The presently described duplex PCR assay is capable of simultaneously detecting all of the minor blaNDM-1 variants since the nucleotide changes between the variants are located outside the primer- and probe-binding sequences. Likewise, in the case of blaKPC, the assay described here is expected to amplify all known blaKPC types. Although our duplex PCR assay was validated with Gram-negative bacteria, it could amplify the expected product from all blaKPC- and blaNDM-carrying isolates, including Gram-positive bacteria. Recently, Cunningham SA et al. described a FRET hybridization probe-based real-time PCR assay that targets blaKPC and blaNDM in a single assay . Although the assay performed equivalently to our assay, the FRET hybridization probe is more expensive than ours TaqMan probe. Additionally, the FRET hybridization probe-based real-time PCR assay needs LightCycler instrument(Roche Applied Science, Indianapolis, IN) to match it, which limited its wide application; the classic TaqMan probe in our assay is suitable for any real-time PCR detection system, which has wider applicability.
In conclusion, we successfully established a novel duplex real-time PCR assay for the prompt and simultaneous screening of the blaNDM and blaKPC genes in a single reaction that had good sensitivity and specificity and excellent agreement with conventional PCR and sequencing. The excellent performance of duplex PCR makes it an important tool for guiding the appropriate choice of antimicrobial therapy and helping limit spread of the resistance genes through aggressive infection control measures. Its use would be especially suitable for national epidemiological purposes in an outbreak situation thanks to its comprehensive ability to detect all known blaNDM and blaKPC variants.
Nucleotide sequence accession number
The GenBank accession numbers are JN711113, JN711114, KC404861, KC539432, KC539429, KC539430 and KC539431, for the blaNDM-1 gene from strains 920856, 903966, 917144, 23142, 24192, 27378 and 208741, respectively, and JF431928, JF894295-JF894300, JQ040039, and JQ040040 for the blaKPC-2 gene from nine KPC-2-producing K. pneumonia, respectively. The blaKPC-2 gene of One K. pneumonia carrying both blaKPC-2 and blaIMP-4 genes did not been lodged in GenBank.
Nordmann P, Naas T, Poirel L: Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011, 17: 1791-1798. 10.3201/eid1710.110655
Nordmann P, Dortet L, Poirel L: Carbapenem resistance in Enterobacteriaceae: here is the storm!. Trends Mol Med. 2012, 18: 263-272. 10.1016/j.molmed.2012.03.003
Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR: Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009, 53: 5046-5054. 10.1128/AAC.00774-09
Brink AJ, Coetzee J, Clay CG, Sithole S, Richards GA, Poirel L, Nordmann P: Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa. J Clin Microbiol. 2012, 50: 525-527. 10.1128/JCM.05956-11
Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC: Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001, 45: 1151-1161. 10.1128/AAC.45.4.1151-1161.2001
Poirel L, Lienhard R, Potron A, Malinverni R, Siegrist HH, Nordmann P: Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in a Klebsiella pneumoniae isolate from Switzerland. J Antimicrob Chemother. 2011, 66: 675-676. 10.1093/jac/dkq499
Kumarasamy K, Kalyanasundaram A: Emergence of Klebsiella pneumoniae isolate co-producing NDM-1 with KPC-2 from India. J Antimicrob Chemother. 2012, 67: 243-244. 10.1093/jac/dkr431
Curiao T, Morosini MI, Ruiz-Garbajosa P, Robustillo A, Baquero F, Coque TM, Canton R: Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J Antimicrob Chemother. 2010, 65: 1608-1614. 10.1093/jac/dkq174
Shen P, Wei Z, Jiang Y, Du X, Ji S, Yu Y, Li L: Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob Agents Chemother. 2009, 53: 4333-4338. 10.1128/AAC.00260-09
Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P: Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene. Antimicrob Agents Chemother. 2008, 52: 1257-1263. 10.1128/AAC.01451-07
Poirel L, Dortet L, Bernabeu S, Nordmann P: Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother. 2011, 55: 5403-5407. 10.1128/AAC.00585-11
Potron A, Poirel L, Nordmann P: Plasmid-mediated transfer of the bla(NDM-1) gene in Gram-negative rods. Fems Microbiol Lett. 2011, 324: 111-116. 10.1111/j.1574-6968.2011.02392.x
Chen Y, Zhou Z, Jiang Y, Yu Y: Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother. 2011, 66: 1255-1259. 10.1093/jac/dkr082
Gomez-Gil MR, Pano-Pardo JR, Romero-Gomez MP, Gasior M, Lorenzo M, Quiles I, Mingorance J: Detection of KPC-2-producing Citrobacter freundii isolates in Spain. J Antimicrob Chemother. 2010, 65: 2695-2697. 10.1093/jac/dkq352
Poirel L, Walsh TR, Cuvillier V, Nordmann P: Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011, 70: 119-123. 10.1016/j.diagmicrobio.2010.12.002
Naas T, Ergani A, Carrer A, Nordmann P: Real-time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples. Antimicrob Agents Chemother. 2011, 55: 4038-4043. 10.1128/AAC.01734-10
Diene SM, Bruder N, Raoult D, Rolain JM: Real-time PCR assay allows detection of the New Delhi metallo-beta-lactamase (NDM-1)-encoding gene in France. Int J Antimicrob Agents. 2011, 37: 544-546. 10.1016/j.ijantimicag.2011.02.006
Ong DC, Koh TH, Syahidah N, Krishnan P, Tan TY: Rapid detection of the blaNDM-1 gene by real-time PCR. J Antimicrob Chemother. 2011, 66: 1647-1649. 10.1093/jac/dkr184
Richter SN, Frasson I, Biasolo MA, Bartolini A, Cavallaro A, Palu G: Ultrarapid detection of blaKPC(1)/(2)-(1)(2) from perirectal and nasal swabs by use of real-time PCR. J Clin Microbiol. 2012, 50: 1718-1720. 10.1128/JCM.00195-12
Hindiyeh M, Smollen G, Grossman Z, Ram D, Davidson Y, Mileguir F, Vax M, Ben DD, Tal I, Rahav G, et al: Rapid detection of blaKPC carbapenemase genes by real-time PCR. J Clin Microbiol. 2008, 46: 2879-2883. 10.1128/JCM.00661-08
Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM: Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006, 27: 351-353. 10.1016/j.ijantimicag.2006.01.004
Monteiro J, Widen RH, Pignatari AC, Kubasek C, Silbert S: Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother. 2012, 67: 906-909. 10.1093/jac/dkr563
Cunningham SA, Noorie T, Meunier D, Woodford N, Patel R: Rapid and simultaneous detection of genes encoding Klebsiella pneumoniae carbapenemase (blaKPC) and New Delhi metallo-beta-lactamase (blaNDM) in Gram-negative bacilli. J Clin Microbiol. 2013, 51: 1269-1271. 10.1128/JCM.03062-12
This study was supported by the grant from the Natural Science Foundation of Guangdong Province. (No. S2012010009153), the National Natural Science Foundation of China (No. 30470099), Guangzhou City Science and Technology Project (No. 2010J-E461), the Presidential Foundation of Nanfang Hospital (No. 2010B002) and New Business New Technologies Foundation of Nanfang Hospital (No. 201116).
The authors declare that they have no competing interests.
FZ and JS carried out the design of the primers and probes, the evaluation experiments, data organization and analysis and contributed to writing and to the interpretation of the results. CC carried out duplex real-time PCR assay and the sequence alignment. YR contributed to the design of the study and assisted in the drafting of the manuscript. All authors have read and approved the manuscript.
Fen Zheng, Jingjing Sun contributed equally to this work.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Zheng, F., Sun, J., Cheng, C. et al. The establishment of a duplex real-time PCR assay for rapid and simultaneous detection of blaNDM and blaKPC genes in bacteria. Ann Clin Microbiol Antimicrob 12, 30 (2013). https://doi.org/10.1186/1476-0711-12-30
- Real-time PCR
- Infection control